North America Newborn Screening Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2028 |
 Market Size (Base Year) |
|
 Market Size (Forecast Year) |
|
 CAGR |
% |
| Major Markets Players |
|
>北美新生儿筛查市场，按测试类型（干血斑测试、听力筛查测试、严重先天性心脏病 (CCHD) 测试）、产品类型（仪器、试剂和检测试剂盒）、技术（串联质谱法、听力筛查技术、脉搏血氧饱和度筛查技术、免疫测定和酶测定、电泳法、基于 DNA 的测定）、疾病类型（严重先天性心脏病、新生儿听力损失、镰状细胞病、苯丙酮尿症 (PKU)、囊性纤维化 (CF)、枫糖尿病、其他）、最终用户（医院、儿科诊所、诊所）、国家（美国、加拿大、墨西哥）行业趋势和预测到 2028 年。
市场分析与洞察：北美新生儿筛查市场
预计在 2021 年至 2028 年的预测期内，北美新生儿筛查市场将以 13.83% 的速度增长。Data Bridge Market Research 关于北美新生儿筛查市场的报告提供了有关预测期内预计普遍存在的各种因素的分析和见解，同时提供了它们对市场增长的影响。政府为提高人们对新生儿筛查的认识而采取的举措不断增多，这正在加速北美新生儿筛查市场的增长。
众所周知，新生儿筛查是一种检测方法，可以识别新生儿中可能对其长期健康造成严重损害的致命和有害疾病。
预计在预测期内推动北美新生儿筛查市场增长的主要因素是新生儿人口基数的增加。此外，预计新生儿先天性疾病病例的增加将进一步推动北美新生儿筛查市场的增长。此外，适当的政府计划和立法预计将进一步缓冲北美新生儿筛查市场的增长。另一方面，自动化技术费用的增加和小型关键参与者的激烈竞争预计将进一步阻碍北美新生儿筛查市场在这段时间内的增长。
此外，技术发展将为未来几年北美新生儿筛查市场的增长提供潜在机会。然而，全球缺乏统一的新生儿筛查政策和程序，这可能会在不久的将来进一步挑战北美新生儿筛查市场的增长。
这份北美新生儿筛查市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入来源、市场法规变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新等方面的机会。如需了解有关北美新生儿筛查市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报。我们的团队将帮助您做出明智的市场决策，以实现市场增长。
北美 新生儿筛查 市场范围和市场规模
北美新生儿筛查市场根据检测类型、产品类型、技术、疾病类型和最终用户进行细分。这些细分市场之间的增长将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
- 根据测试类型，北美新生儿筛查市场分为干血斑测试、听力筛查测试和严重先天性心脏病 (CCHD) 测试。
- 根据产品类型，北美新生儿筛查市场分为仪器、试剂和检测试剂盒。
- 根据技术，北美新生儿筛查市场分为串联质谱法、听力筛查技术、脉搏血氧饱和度筛查技术、免疫测定和酶测定、电泳法、基于 DNA 的测定。
- 根据疾病类型，北美新生儿筛查市场分为苯丙酮尿症(PKU)、囊性纤维化 (CF)、镰状细胞病、新生儿听力损失、严重先天性心脏病、枫糖尿病等。
- 根据最终用户，北美新生儿筛查市场分为儿科诊所、医院和诊所。
北美 新生儿筛查 市场国家级分析
北美新生儿筛查市场根据测试类型、产品类型、技术、疾病类型和最终用户进行细分。
北美新生儿筛查市场报告涵盖的国家包括北美的美国、加拿大和墨西哥。
由于先天性疾病的患病率上升以及全美 50 个州强制检测，美国在北美新生儿筛查市场占据主导地位。此外，新生儿疾病发病率的上升和对先进系统的需求的上升预计将在预测期内进一步推动北美新生儿筛查市场的增长。
北美新生儿筛查市场报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。消费量、生产地点和数量、进出口分析、价格趋势分析、原材料成本、下游和上游价值链分析等数据点是用于预测各个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税的影响以及贸易路线。
医疗保健基础设施增长安装基础和新技术渗透
北美新生儿筛查市场还为您提供每个国家/地区资本设备医疗保健支出增长、北美新生儿筛查市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管情景的变化及其对北美新生儿筛查市场的影响的详细市场分析。数据适用于 2010-2019 年的历史时期。
竞争格局和北美 新生儿筛查 市场份额分析
北美新生儿筛查市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对北美新生儿筛查市场的关注有关。
北美新生儿筛查市场报告中涉及的主要参与者包括 PerkinElmer Inc.、Natus Medical Incorporated、Trivitron Healthcare、Baebies, Inc.、Bio-Rad Laboratories, Inc.、Danahar、Hill-Rom Services Inc.、Intelligent Hearing Systems、Interacoustics A/S、Masimo、Medtronic、Otodynamics Ltd、Vivosonic Inc.、ZenTech SA 等。DBMR 分析师了解竞争优势，并为每个竞争对手分别提供竞争分析。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA NEWBORN SCREENING MARKET
1.4 LIMITATIONS
1.5 CURRENCY AND PRICING
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 SECONDARY SOURCES
2.7 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 RISING PREVALENCE OF NEWBORN SCREENING
3.1.2 GROWTH IN NEONATAL DISEASES
3.1.3 INCREASED GOVERNMENT INITIATIVES
3.1.4 TECHNOLOGICAL ADVANCEMENTS IN SCREENING
3.2 RESTRAINTS
3.2.1 STRINGENT REGULATORY POLICIES
3.2.2 HIGH COST OF AUTOMATED DEVICES
3.3 OPPORTUNITIES
3.3.1 NEXT-GENERATION SEQUENCING TECHNOLOGY FOR NEWBORN SCREENING
3.3.2 EMERGING MARKET
3.4 CHALLENGES
3.4.1 SOCIO ECONOMIC BARRIERS
3.4.2 LACK OF SKILLED PROFESSIONALS
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 NORTH AMERICA NEWBORN SCREENING MARKET, BY TEST TYPE
6.1 OVERVIEW
6.2 DRIED BLOOD SPOT TEST
6.3 HEARING SCREEN TEST
6.4 CRITICAL CONGENITAL HEART DISEASES (CCHD) TEST
7 NORTH AMERICA NEWBORN SCREENING MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 INSTRUMENTS
7.2.1 NEWBORN DISORDER SCREENING INSTRUMENTS
7.2.2 NEWBORN HEARING SCREENING INSTRUMENTS
7.2.3 PULSE OXIMETER
7.3 REAGENTS AND ASSAY KITS
8 NORTH AMERICA NEWBORN SCREENING MARKET, BY TECHNOLOGY
8.1 OVERVIEW
8.2 TANDEM MASS SPECTROMETRY
8.3 HEARING SCREEN TECHNOLOGY
8.4 PULSE OXIMETRY SCREENING TECHNOLOGY
8.5 IMMUNOASSAYS AND ENZYMATIC ASSAYS
8.6 ELECTROPHORESIS
8.7 DNA-BASED ASSAYS
9 NORTH AMERICA NEWBORN SCREENING MARKET, BY DISEASE TYPE
9.1 OVERVIEW
9.2 CRITICAL CONGENITAL HEART DISEASES
9.3 NEWBORN HEARING LOSS
9.4 SICKLE CELL DISEASE
9.5 PHENYLKETONURIA (PKU)
9.6 CYSTIC FIBROSIS (CF)
9.7 MAPLE SYRUP URINE DISEASE
9.8 OTHERS
10 NORTH AMERICA NEWBORN SCREENING MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITAL
10.3 PEDIATRIC CLINICS
10.4 CLINICS
11 NORTH AMERICA NEWBORN SCREENING MARKET, BY GEOGRAPHY
11.1 NORTH AMERICA
11.1.1 U.S.
11.1.2 CANADA
11.1.3 MEXICO
12 NORTH AMERICA NEWBORN SCREENING MARKET, COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
13 COMPANY PROFILES
13.1 PERKINELMER INC.
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 PRODUCT PORTFOLIO
13.1.4 RECENT DEVELOPMENTS
13.2 NATUS MEDICAL INCORPORATED
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 PRODUCT PORTFOLIO
13.2.4 RECENT DEVELOPMENTS
13.3 TRIVITRON HEALTHCARE
13.3.1 COMPANY SNAPSHOT
13.3.2 PRODUCT PORTFOLIO
13.3.3 RECENT DEVELOPMENTS
13.4 BAEBIES, INC.
13.4.1 COMPANY SNAPSHOT
13.4.2 PRODUCT PORTFOLIO
13.4.3 RECENT DEVELOPMENTS
13.5 BIO-RAD LABORATORIES, INC.
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 PRODUCT PORTFOLIO
13.5.4 RECENT DEVELOPMENT
13.6 DANAHER
13.6.1 COMPANY SNAPSHOT
13.6.2 REVENUE ANALYSIS
13.6.3 PRODUCT PORTFOLIO
13.6.4 RECENT DEVELOPMENT
13.7 HILL-ROM SERVICES INC.
13.7.1 COMPANY SNAPSHOT
13.7.2 REVENUE ANALYSIS
13.7.3 PRODUCT PORTFOLIO
13.7.4 RECENT DEVELOPMENT
13.8 INTELLIGENT HEARING SYSTEMS
13.8.1 COMPANY SNAPSHOT
13.8.2 PRODUCT PORTFOLIO
13.8.3 RECENT DEVELOPMENT
13.9 INTERACOUSTICS A/S
13.9.1 COMPANY SNAPSHOT
13.9.2 PRODUCT PORTFOLIO
13.9.3 RECENT DEVELOPMENTS
13.1 MASIMO
13.10.1 COMPANY SNAPSHOT
13.10.2 REVENUE ANALYSIS
13.10.3 PRODUCT PORTFOLIO
13.10.4 RECENT DEVELOPMENT
13.11 MEDTRONIC
13.11.1 COMPANY SNAPSHOT
13.11.2 REVENUE ANALYSIS
13.11.3 PRODUCT PORTFOLIO
13.11.4 RECENT DEVELOPMENT
13.12 OTODYNAMICS LTD
13.12.1 COMPANY SNAPSHOT
13.12.2 PRODUCT PORTFOLIO
13.12.3 RECENT DEVELOPMENTS
13.13 VIVASONIC INC.
13.13.1 COMPANY SNAPSHOT
13.13.2 PRODUCT PORTFOLIO
13.13.3 RECENT DEVELOPMENTS
13.14 ZENTECH S.A.
13.14.1 COMPANY SNAPSHOT
13.14.2 PRODUCT PORTFOLIO
13.14.3 RECENT DEVELOPMENTS
14 QUESTIONNAIRE
15 RELATED REPORTS
表格列表
TABLE 1 NEWBORN SCREENING PROGRAM (2015 & 2016) IN THE U.S.
TABLE 2 NEONATAL MORTALITY RATE (DEATHS PER 1,000 LIVE BIRTHS), IN BETWEEN 2015 -2018
TABLE 3 PREVALENCE OF DISORDERS AMONG FILIPINO NEWBORNS (1996-2016)
TABLE 4 NUMBER OF BIRTHS IN NORTHERN HEMISPHERE (2018)
TABLE 5 PREVALENCE OF DISORDERS AMONG NORTHERN HEMISPHERE (2018)
TABLE 6 COSTS OF NEXT GENENARATION SEQUENCING DEVICES (USD MILLION)
TABLE 7 HEALTHCARE EXPENDITURE IN ASIA PACIFIC (USD MILLION)
TABLE 8 COMPARISON OF THE ECONOMIC PROSPERITY AND ANNUAL PERCENTAGE OF NEWBORN BABIES SCREENED IN SELECTED DEVELOPING NATIONS
TABLE 9 NORTH AMERICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)
TABLE 10 NORTH AMERICA DRIED BLOOD SPOT TEST IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 11 NORTH AMERICA HEARING SCREEN TEST IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 12 NORTH AMERICA CRITICAL CONGENITAL HEART DISEASES TEST IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 13 NORTH AMERICA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 14 NORTH AMERICA PRODUCT IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 15 NORTH AMERICA INSTRUMENTS IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 16 NORTH AMERICA REAGENTS AND ASSAY KITS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 17 NORTH AMERICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
TABLE 18 NORTH AMERICA TANDEM MASS SPECTROMETRY IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 19 NORTH AMERICA HEARING SCREEN TECHNOLOGY IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 20 NORTH AMERICA PULSE OXIMETRY SCREENING TECHNOLOGY IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 21 NORTH AMERICA IMMUNOASSAYS AND ENZYMATIC ASSAYS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 22 NORTH AMERICA ELECTROPHORESIS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 23 NORTH AMERICA DNA-BASED ASSAYS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 24 NORTH AMERICA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
TABLE 25 NORTH AMERICA CRITICAL CONGENITAL HEART DISEASES IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 26 NORTH AMERICA NEWBORN HEARING LOSS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 27 NORTH AMERICA SICKLE CELL DISEASE IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 28 NORTH AMERICA PHENYLKETONURIA IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 29 NORTH AMERICA CYSTIC FIBROSIS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 30 NORTH AMERICA MAPLE SYRUP URINE DISEASE IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 31 NORTH AMERICA OTHERS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 32 NORTH AMERICA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 33 NORTH AMERICA HOSPITAL IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 34 NORTH AMERICA PEDIATRIC CLINICS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 35 NORTH AMERICA CLINICS IN NEWBORN SCREENING MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 36 NORTH AMERICA NEWBORN SCREENING MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 37 NORTH AMERICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)
TABLE 38 NORTH AMERICA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 39 NORTH AMERICA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 40 NORTH AMERICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
TABLE 41 NORTH AMERICA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
TABLE 42 NORTH AMERICA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 43 U.S. NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)
TABLE 44 U.S. NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 45 U.S. INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 46 U.S. NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
TABLE 47 U.S. NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
TABLE 48 U.S. NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 49 CANADA NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)
TABLE 50 CANADA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 51 CANADA INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 52 CANADA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
TABLE 53 CANADA NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
TABLE 54 CANADA NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 55 MEXICO NEWBORN SCREENING MARKET, BY TEST TYPE, 2017-2026 (USD MILLION)
TABLE 56 MEXICO NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 57 MEXICO INSTRUMENT IN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 58 MEXICO NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
TABLE 59 MEXICO NEWBORN SCREENING MARKET, BY DISEASE TYPE, 2017-2026 (USD MILLION)
TABLE 60 MEXICO NEWBORN SCREENING MARKET, BY END USER, 2017-2026 (USD MILLION)
图片列表
FIGURE 1 NORTH AMERICA NEWBORN SCREENING MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA NEWBORN SCREENING MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA NEWBORN SCREENING MARKET: RESEARCH SNAPSHOT
FIGURE 4 NORTH AMERICA NEWBORN SCREENING MARKET: NORTH AMERICA VS. REGIONAL ANALYSIS
FIGURE 5 NORTH AMERICA NEWBORN SCREENING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA NEWBORN SCREENING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 DRIVER, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA NEWBORN SCREENING MARKET
FIGURE 8 NEONATAL MORTALITY RATE (PER 1000 LIVE BIRTHS) (2010-2016)
FIGURE 9 NEONATAL MORTALITY RATE (PER 1000 LIVE BIRTHS) (2010-2017)
FIGURE 10 VARIOUS CAUSES OF NEONATAL DEATH WORLDWIDE EACH YEAR
FIGURE 11 HEALTH CARE EXPENDITURE (USD MILLION)
FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE NORTH AMERICA NEWBORN SCREENING MARKET AND ASIA- PACIFIC IS EXPECTED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 13 GROWTH IN NEONATAL DISEASES IS EXPECTED TO DRIVE THE MARKET FOR NEWBORN SCREENING IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 14 DRIED BLOOD SPOT TEST IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA NEWBORN SCREENING MARKET IN 2019
FIGURE 15 NORTH AMERICA NEWBORN SCREENING MARKET: BY TEST TYPE, 2018
FIGURE 16 NORTH AMERICA NEWBORN SCREENING MARKET: BY PRODUCT TYPE, 2018
FIGURE 17 NORTH AMERICA NEWBORN SCREENING MARKET: BY TECHNOLOGY, 2018
FIGURE 18 NORTH AMERICA NEWBORN SCREENING MARKET: BY DISEASE TYPE, 2018
FIGURE 19 NORTH AMERICA NEWBORN SCREENING MARKET: BY END USER, 2018
FIGURE 20 NORTH AMERICA NEWBORN SCREENING MARKET: SNAPSHOT (2018)
FIGURE 21 NORTH AMERICA NEWBORN SCREENING MARKET: BY COUNTRY (2018)
FIGURE 22 NORTH AMERICA NEWBORN SCREENING MARKET: BY COUNTRY (2019 & 2026)
FIGURE 23 NORTH AMERICA NEWBORN SCREENING MARKET: BY COUNTRY (2018 & 2026)
FIGURE 24 NORTH AMERICA NEWBORN SCREENING MARKET: BY TEST TYPE (2019-2026)
FIGURE 25 NORTH AMERICA NEWBORN SCREENING MARKET: COMPANY SHARE 2017 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
